Today, a brief rundown of news involving Merck and Vanda Pharmaceuticals, as well as updates from Sanofi and Novo Holdings that you may have missed. Novartis and BioMarin Pharmaceutical, in striking ...

The tradipitant saga stretches back to September 2024, when the FDA declined to approve Vanda’s drug in gastroparesis, a stomach condition characterized by delayed gastric emptying. Vanda ...

Vanda Pharmaceuticals (NASDAQ:VNDA) is alleging that members of the U.S. FDA "have committed to delay" its request for a hearing to discuss the agency's issuing of a Complete Response Letter in ...

WASHINGTON, April 23, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda") (Nasdaq: VNDA) today announced that FDA bureaucrats have committed to delay Vanda's request for a hearing on the ...

Vanda Pharmaceuticals is suing the FDA again, this time alleging the agency is unlawfully delaying a hearing to discuss the rejection of the biotech's stomach disorder drug last year. The FDA has ...

British drug­mak­er As­traZeneca is re­join­ing the drug in­dus­try’s ma­jor US lob­by­ing group, PhRMA, rough­ly two years af­ter quit­ting the or­ga­ni­za­tion.

For the first time since the Trump ad­min­is­tra­tion’s ma­jor staff cuts at the FDA this month, the agency pub­licly an­nounced that the fir­ings will lead … ...

The Vanda Miss Joaquim was born and bred in Singapore in 1893, in the garden of a woman named Agnes Joaquim, an Armenian horticulturist who lived in Tanjong Pagar.